Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obesity

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    July 2021
  1. WANG L, Zhou B, Zhao Z, Yang L, et al
    Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18.
    Lancet. 2021;398:53-63.
    PubMed     Abstract available


  2. FLEGAL KM
    BMI and obesity trends in Chinese national survey data.
    Lancet. 2021;398:5-7.
    PubMed    


  3. SALAH RO, Ghandour R, Husseini A
    Prevalence of overweight, obesity, and associated factors among adolescents in the occupied Palestinian territory: a cross-sectional study.
    Lancet. 2021;398 Suppl 1:S46.
    PubMed     Abstract available


    June 2021
  4. TREASURE J, Ambwani S
    Addressing weight stigma and anti-obesity rhetoric in policy changes to prevent eating disorders.
    Lancet. 2021 Jun 3. pii: S0140-6736(21)01109.
    PubMed    


    May 2021
  5. ENEBO LB, Berthelsen KK, Kankam M, Lund MT, et al
    Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial.
    Lancet. 2021;397:1736-1748.
    PubMed     Abstract available


  6. SYN NL, Cummings DE, Wang LZ, Lin DJ, et al
    Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.
    Lancet. 2021 May 6. pii: S0140-6736(21)00591.
    PubMed     Abstract available


    April 2021
  7. BECERRIL S, Fruhbeck G
    Cagrilintide plus semaglutide for obesity management.
    Lancet. 2021 Apr 22. pii: S0140-6736(21)00944.
    PubMed    


    March 2021
  8. LATINI R, Staszewsky L
    Semaglutide and effective weight control.
    Lancet. 2021;397:942-943.
    PubMed    


  9. DAVIES M, Faerch L, Jeppesen OK, Pakseresht A, et al
    Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
    Lancet. 2021 Mar 2. pii: S0140-6736(21)00213.
    PubMed     Abstract available


    November 2020
  10. CHAN JCN, Lim LL, Wareham NJ, Shaw JE, et al
    The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32374.
    PubMed    


    September 2020
  11. HAWKES C, Ruel M, Wells JC, Popkin BM, et al
    The double burden of malnutrition-further perspective - Authors' reply.
    Lancet. 2020;396:815-816.
    PubMed    


  12. STEWART CP, de Pee S, Maleta K, Michaelsen KF, et al
    The double burden of malnutrition-further perspective.
    Lancet. 2020;396:814-815.
    PubMed    


  13. OSENDARP SJM, Brown KH, Neufeld LM, Udomkesmalee E, et al
    The double burden of malnutrition-further perspective.
    Lancet. 2020;396:813.
    PubMed    


  14. HOSSAIN MS, Ferdous S, Raheem E, Siddiqee MH, et al
    The double burden of malnutrition-further perspective.
    Lancet. 2020;396:813-814.
    PubMed    


    May 2020
  15. KASS DA, Duggal P, Cingolani O
    Obesity could shift severe COVID-19 disease to younger ages.
    Lancet. 2020 May 4. pii: S0140-6736(20)31024.
    PubMed    


    January 2020
  16. WILLIAMS R, Aithal G, Alexander GJ, Allison M, et al
    Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.
    Lancet. 2020;395:226-239.
    PubMed     Abstract available


    December 2019
  17. WELLS JC, Sawaya AL, Wibaek R, Mwangome M, et al
    The double burden of malnutrition: aetiological pathways and consequences for health.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32472.
    PubMed     Abstract available


  18. HAWKES C, Ruel MT, Salm L, Sinclair B, et al
    Double-duty actions: seizing programme and policy opportunities to address malnutrition in all its forms.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32506.
    PubMed     Abstract available


  19. POPKIN BM, Corvalan C, Grummer-Strawn LM
    Dynamics of the double burden of malnutrition and the changing nutrition reality.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32497.
    PubMed     Abstract available


  20. NUGENT R, Levin C, Hale J, Hutchinson B, et al
    Economic effects of the double burden of malnutrition.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32473.
    PubMed     Abstract available


    October 2019
  21. MUSELLA M, Vitiello A
    The YOMEGA non-inferiority trial.
    Lancet. 2019;394:1412.
    PubMed    


  22. ROBERT M, Maucort-Boulch D, Delaunay D, Disse E, et al
    The YOMEGA non-inferiority trial - Authors' reply.
    Lancet. 2019;394:1412-1413.
    PubMed    


  23. BERGEAT D, Sulpice L, Meunier B, Boudjema K, et al
    The YOMEGA non-inferiority trial.
    Lancet. 2019;394:1411-1412.
    PubMed    


  24. EL FARA H
    The YOMEGA non-inferiority trial.
    Lancet. 2019;394:1411.
    PubMed    


  25. THE LANCET
    Child nutrition: the need for courageous action.
    Lancet. 2019;394:1387.
    PubMed    


  26. MYTTON OT, Fenton-Glynn C, Pawson E, Viner RM, et al
    Protecting children's rights: why governments must be bold to tackle childhood obesity.
    Lancet. 2019 Oct 10. pii: S0140-6736(19)32274.
    PubMed    


  27. XIAO Y, Sun L
    Semaglutide in weight management.
    Lancet. 2019;394:1226.
    PubMed    


  28. WILDING JPH
    Semaglutide in weight management - Author's reply.
    Lancet. 2019;394:1226-1227.
    PubMed    


    August 2019

  29. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Abstract available


  30. BARNETT R
    Type 2 diabetes.
    Lancet. 2019;394:557.
    PubMed    


  31. LEVAILLANT M, Lievre G, Baert G
    Ending diabetes in Mexico.
    Lancet. 2019;394:467-468.
    PubMed    


    July 2019

  32. The slowdown in eradicating hunger.
    Lancet. 2019;394:274.
    PubMed    


    April 2019
  33. RENEHAN AG, Lloyd K, Renehan I
    Awareness of the link between obesity and cancer in UK school curricula.
    Lancet. 2019;393:1591-1592.
    PubMed    


    March 2019
  34. MADSBAD S, Holst JJ
    Bariatric surgery-which procedure is the optimal choice?
    Lancet. 2019;393:1263-1264.
    PubMed    


  35. MASA JF, Mokhlesi B, Benitez I, Gomez de Terreros FJ, et al
    Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial.
    Lancet. 2019 Mar 29. pii: S0140-6736(18)32978.
    PubMed     Abstract available


  36. MURPHY PB, Piper AJ, Hart N
    Obesity hypoventilation syndrome: is less really more?
    Lancet. 2019 Mar 29. pii: S0140-6736(19)30248.
    PubMed    


  37. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    PubMed     Abstract available


  38. ROBERT M, Espalieu P, Pelascini E, Caiazzo R, et al
    Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
    Lancet. 2019 Mar 6. pii: S0140-6736(19)30475.
    PubMed     Abstract available


  39. THE LANCET
    Health and wellbeing in adolescence and early adulthood.
    Lancet. 2019;393:847.
    PubMed    


    February 2019
  40. NUGENT R
    Rethinking systems to reverse the global syndemic.
    Lancet. 2019;393:726-728.
    PubMed    


  41. DA SILVA JG
    Transforming food systems for better health.
    Lancet. 2019;393:e30-e31.
    PubMed    


  42. MENDENHALL E, Singer M
    The global syndemic of obesity, undernutrition, and climate change.
    Lancet. 2019 Feb 11. pii: S0140-6736(19)30310.
    PubMed    


    January 2019
  43. KLEINERT S, Horton R
    Obesity needs to be put into a much wider context.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)33192.
    PubMed    


  44. DAVIES R
    William Dietz: shaping science and policy on obesity.
    Lancet. 2019 Jan 25. pii: S0140-6736(19)30147.
    PubMed    


  45. SWINBURN BA, Kraak VI, Allender S, Atkins VJ, et al
    The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)32822.
    PubMed    


  46. THE LANCET
    2019: the year for nutrition.
    Lancet. 2019;393:200.
    PubMed    


    December 2018
  47. SANYAL A, Charles ED, Neuschwander-Tetri BA, Loomba R, et al
    Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)31785.
    PubMed     Abstract available


  48. WILLIAMS R, Alexander G, Aspinall R, Batterham R, et al
    Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2018;392:2398-2412.
    PubMed     Abstract available


    November 2018
  49. UNAMUNO X, Fruhbeck G
    Lorcaserin: balancing efficacy with potential risks.
    Lancet. 2018;392:2239-2240.
    PubMed    


    October 2018
  50. TAYLOR R, Adamson AJ, Sattar N, Lean MEJ, et al
    VLCD for weight loss and remission of type 2 diabetes? - Authors' reply.
    Lancet. 2018;392:1307.
    PubMed    


  51. AHMAD N, Alfaris N
    VLCD for weight loss and remission of type 2 diabetes?
    Lancet. 2018;392:1306-1307.
    PubMed    


  52. RALSTON J, Brinsden H, Buse K, Candeias V, et al
    Time for a new obesity narrative.
    Lancet. 2018 Oct 10. pii: S0140-6736(18)32537.
    PubMed    


  53. BOHULA EA, Scirica BM, Inzucchi SE, McGuire DK, et al
    Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32328.
    PubMed     Abstract available


    August 2018
  54. O'NEIL PM, Birkenfeld AL, McGowan B, Mosenzon O, et al
    Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
    Lancet. 2018 Aug 16. pii: S0140-6736(18)31773.
    PubMed     Abstract available


    June 2018
  55. RAYNER CK, Horowitz M
    Agonism of receptors in the gut-pancreas axis in type 2 diabetes: are two better than one?
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30936.
    PubMed    


  56. AMBERY P, Parker VE, Stumvoll M, Posch MG, et al
    MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30726.
    PubMed     Abstract available


    May 2018
  57. EZZATI M, Di Cesare M, Bentham J
    Determining the worldwide prevalence of obesity - Authors' reply.
    Lancet. 2018;391:1774.
    PubMed    


  58. REILLY JJ, El-Hamdouchi A, Diouf A, Monyeki A, et al
    Determining the worldwide prevalence of obesity.
    Lancet. 2018;391:1773-1774.
    PubMed    


  59. FLEMING TP, Watkins AJ, Velazquez MA, Mathers JC, et al
    Origins of lifetime health around the time of conception: causes and consequences.
    Lancet. 2018;391:1842-1852.
    PubMed     Abstract available


    March 2018
  60. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Abstract available


  61. BUCHBINDER R, van Tulder M, Oberg B, Costa LM, et al
    Low back pain: a call for action.
    Lancet. 2018 Mar 20. pii: S0140-6736(18)30488.
    PubMed     Abstract available


    January 2018
  62. ABDULHUSSEIN D, Amin E
    Translation of the link between cancer and obesity to patients.
    Lancet. 2018;391:121-122.
    PubMed    


  63. SELBIE D
    Reducing childhood obesity in the UK.
    Lancet. 2018;391:26.
    PubMed    


  64. BRAILLON A
    Reducing childhood obesity in the UK and France.
    Lancet. 2018;391:26.
    PubMed    


    November 2017
  65. WILLIAMS R, Alexander G, Armstrong I, Baker A, et al
    Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)32866.
    PubMed     Abstract available


    October 2017
  66. THE LANCET
    The link between cancer and obesity.
    Lancet. 2017;390:1716.
    PubMed    



  67. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32129.
    PubMed     Abstract available


  68. DIETZ WH
    Double-duty solutions for the double burden of malnutrition.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32479.
    PubMed    


    September 2017
  69. JURECIC A, Marchalik D
    On obesity: Roxane Gay's Hunger.
    Lancet. 2017;390:1577.
    PubMed    


    August 2017
  70. THE LANCET
    The UK's inadequate plan for reducing childhood obesity.
    Lancet. 2017;390:822.
    PubMed    


    June 2017
  71. ANGADI SS, Gaesser GA
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2285.
    PubMed    


  72. DI ANGELANTONIO E, Bhupathiraju SN, Hu FB, Danesh J, et al
    Body-mass index and all-cause mortality - Authors' reply.
    Lancet. 2017;389:2285-2286.
    PubMed    


  73. FLEGAL KM
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284-2285.
    PubMed    


  74. PEPPER DJ, Sun J, Suffredini AF, Kadri S, et al
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284.
    PubMed    


  75. VINER R, White B, Christie D
    Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden.
    Lancet. 2017;389:2252-2260.
    PubMed     Abstract available


    April 2017
  76. KIRCHHOF P
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Abstract available


  77. AVEYARD P, Nickless A, Jebb S
    Obesity management in primary care - Authors' reply.
    Lancet. 2017;389:1606-1607.
    PubMed    


  78. HIGUCHI A, Kami M
    Obesity management in primary care.
    Lancet. 2017;389:1606.
    PubMed    


  79. STURGISS EA, Haesler E, Elmitt N, Douglas K, et al
    Obesity management in primary care.
    Lancet. 2017;389:1605.
    PubMed    


  80. BOOTH HP, Gulliford MC
    Obesity management in primary care.
    Lancet. 2017;389:1605-1606.
    PubMed    


    February 2017
  81. LE ROUX CW, Astrup A, Fujioka K, Greenway F, et al
    3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    Lancet. 2017 Feb 22. pii: S0140-6736(17)30069.
    PubMed     Abstract available


    January 2017
  82. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women.
    Lancet. 2017 Jan 31. pii: S0140-6736(16)32380.
    PubMed     Abstract available


  83. THE LANCET
    Obesity and diabetes in 2017: a new year.
    Lancet. 2017;389:1.
    PubMed    


    November 2016
  84. ROYO-BORDONADA MA
    Setting up childhood obesity policies in Europe.
    Lancet. 2016;388:2475.
    PubMed    


    October 2016
  85. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Abstract available


  86. SWINBURN B, Arroll B
    Rethinking primary care systems for obesity.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31913.
    PubMed    


  87. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Abstract available


  88. SIGMON SC
    Additive burdens of malnutrition, poverty, and substance abuse.
    Lancet. 2016;388:1879-1880.
    PubMed    


  89. LI B, Lin R, Liu W, Chen J, et al
    Differences in perceived causes of childhood obesity between migrant and local communities in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S3.
    PubMed     Abstract available


    September 2016
  90. LI F, Liu Y, Zhu W, Harmer P, et al
    China's challenges in promoting physical activity and fitness.
    Lancet. 2016;388:1278-9.
    PubMed    


    August 2016
  91. MANN J, Morenga LT, McLean R, Swinburn B, et al
    Dietary guidelines on trial: the charges are not evidence based.
    Lancet. 2016;388:851-3.
    PubMed    


  92. FREEDHOFF Y, Hall KD
    Weight loss diet studies: we need help not hype.
    Lancet. 2016;388:849-51.
    PubMed    


  93. BERRIGAN D, Troiano RP, Graubard BI
    BMI and mortality: the limits of epidemiological evidence.
    Lancet. 2016;388:734-6.
    PubMed    


    July 2016
  94. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: